...
首页> 外文期刊>Cellular & molecular biology letters. >Detection of a novel mutation in exon 20 of the BRCA1 gene
【24h】

Detection of a novel mutation in exon 20 of the BRCA1 gene

机译:检测BRCA1基因第20外显子的新突变

获取原文
获取原文并翻译 | 示例
           

摘要

Hereditary breast cancer constitutes 5-10% of all breast cancer cases. Inherited mutations in the BRCA1 and BRCA2 tumor-suppressor genes account for the majority of hereditary breast cancer cases. The BRCA1 C-terminal region (BRCT) has a functional duplicated globular domain, which helps with DNA damage repair and cell cycle checkpoint protein control. More than 100 distinct BRCA1 missense variants with structural and functional effects have been documented within the BRCT domain. Interpreting the results of mutation screening of tumor-suppressor genes that can have high-risk susceptibility mutations is increasingly important in clinical practice. This study includes a novel mutation, p.His1746 Pro (c.5237A>C), which was found in BRCA1 exon 20 of a breast cancer patient. In silico analysis suggests that this mutation could alter the stability and orientation of the BRCT domain and the differential binding of the BACH1 substrate.
机译:遗传性乳腺癌占所有乳腺癌病例的5-10%。 BRCA1和BRCA2肿瘤抑制基因的遗传突变占遗传性乳腺癌病例的大多数。 BRCA1 C末端区域(BRCT)具有功能重复的球状结构域,可帮助修复DNA损伤和控制细胞周期检查点蛋白。在BRCT域中已记录了100多个具有结构和功能作用的独特BRCA1错义变体。解释可能具有高风险易感性突变的肿瘤抑制基因的突变筛选结果在临床实践中变得越来越重要。这项研究包括一个新的突变p.His1746 Pro(c.5237A> C),该突变在乳腺癌患者的BRCA1外显子20中发现。电脑分析表明该突变可能会改变BRCT域的稳定性和方向以及BACH1底物的差异结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号